TABLE 1.
Relationships between the expressions of the IRGs and the clinicopathological characteristics in cervical cancer.
| Id | Age | Stage | Grade | M | N | T | BMI |
| t(p) | t(p) | t(p) | t(p) | t(p) | t(p) | t(p) | |
| LTA | −1.168(0.293) | 0.527 (0.608) | −1.462(0.148) | 1.984 (0.103) | 0.07 (0.945) | 0.668 (0.529) | −2.633(0.010) |
| TFRC | −0.149(0.886) | 0.811 (0.431) | 1.066 (0.290) | 1.004 (0.364) | −1.127(0.271) | −7.596(1.456e−04) | 0.948 (0.347) |
| TYK2 | 0.31 (0.766) | −0.047(0.963) | −0.252(0.802) | −0.764(0.500) | 0.503 (0.618) | 1.611 (0.162) | −0.068(0.946) |
| DLL4 | 1.257 (0.235) | −0.259(0.798) | 0.038 (0.970) | −0.065(0.952) | 0.846 (0.403) | −0.818(0.452) | 0.249 (0.804) |
| CSK | 0 (1.000) | −1.261(0.224) | −0.23(0.819) | 1.887 (0.138) | 0.102 (0.919) | 2.566 (0.050) | 1.782 (0.081) |
| JUND | 0.721 (0.492) | 1.523 (0.153) | 0.764 (0.448) | −0.819(0.472) | −0.067(0.947) | −0.473(0.659) | −1.485(0.142) |
| NFATC4 | 1.557 (0.156) | 0.66 (0.520) | 0.178 (0.859) | −0.846(0.458) | −0.016(0.987) | 0.933 (0.396) | −1.993(0.050) |
| SBDS | −0.446(0.669) | −0.019(0.985) | 0.643 (0.522) | 0.884 (0.438) | −0.667(0.511) | −0.676(0.535) | 1.376 (0.176) |
| FLT1 | 0.348 (0.736) | −0.347(0.733) | −0.478(0.634) | 0.6 (0.588) | −0.068(0.946) | −1.14(0.298) | −0.061(0.952) |
| IL17RD | 0.521 (0.617) | −0.709(0.490) | −0.475(0.636) | 0.46 (0.670) | 0.734 (0.467) | 3.091 (0.004) | −2.338(0.022) |
| IL3RA | 4.431(1.404e−04) | 0.905 (0.378) | −1.234(0.221) | 0.094 (0.930) | −0.918(0.365) | 1.262 (0.261) | −2.366(0.020) |
| SDC1 | −2.491(0.034) | 0.228 (0.823) | 2.122 (0.038) | 1.035 (0.370) | −1.724(0.098) | −2.498(0.048) | 1.131 (0.261) |
| PLAU | −0.922(0.394) | −1.368(0.189) | −0.344(0.732) | 1.174 (0.314) | 0.517 (0.609) | −0.892(0.416) | 2.693 (0.010) |
| riskScore | −1.076(0.312) | 0.154 (0.880) | 1.254 (0.215) | 1.864 (0.103) | −0.695(0.495) | −1.819(0.138) | 0.182 (0.856) |
t, t-value of student’s t-test; P, P-value of student’s t-test.